Skip to main content

Orthocell adds to Remplir use cases

16 hours ago

Bookmark

Save articles for future reference.

WA biotech Orthocell has announced a promising new use case for its Remplir nerve regeneration product, this time in reducing post-surgical complications in prostate cancer sufferers.

X

To read our articles you will need to either login or subscribe.